Deutsche Bank Ag\ Beyond Spring Inc. Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.13 - $2.66 $14,909 - $35,096	-13,194 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.68 - $5.01 $2,415 - $7,204	-1,438 Reduced 9.83%	13,194 $29,000
Q4 2021 Feb 11, 2022	SELL	$4.02 - $16.84 $50,201 - $210,297	-12,488 Reduced 46.05%	14,632 $67,000
Q3 2021 Nov 04, 2021	BUY	$9.26 - $31.31 $124,602 - $421,307	13,456 Added 98.48%	27,120 $427,000
Q2 2021 Aug 11, 2021	BUY	$9.37 - $12.12 $12,349 - $15,974	1,318 Added 10.68%	13,664 $143,000
Q1 2021 May 13, 2021	BUY	$10.61 - $15.77 $16,392 - $24,364	1,545 Added 14.3%	12,346 $136,000
Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $31,446 - $53,314	3,080 Added 39.89%	10,801 $131,000
Q3 2020 Nov 12, 2020	BUY	$9.99 - $16.13 $11,168 - $18,033	1,118 Added 16.93%	7,721 $103,000
Q2 2020 Aug 13, 2020	BUY	$11.21 - $18.15 $24,549 - $39,748	2,190 Added 49.63%	6,603 $100,000
Q1 2020 May 14, 2020	SELL	$9.68 - $18.47 $40,723 - $77,703	-4,207 Reduced 48.81%	4,413 $57,000
Q4 2019 Feb 14, 2020	BUY	$11.83 - $18.68 $60,131 - $94,950	5,083 Added 143.71%	8,620 $132,000
Q3 2019 Nov 14, 2019	SELL	$15.33 - $23.85 $46,741 - $72,718	-3,049 Reduced 46.3%	3,537 $62,000
Q2 2019 Aug 14, 2019	BUY	$13.36 - $23.7 $87,988 - $156,088	6,586 New	6,586 $155,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.